NCT06629584ClinicalTrials.gov ↗
This is an open label, phase 2 study investigating asciminib in patients previously treated with one line of TKI therapy.
Asciminib
3 clinical trials involving this therapy/drug
This is not medical advice - consult your oncologist
Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.
NCT06308588ClinicalTrials.gov ↗
To learn if the combination of blinatumomab and asciminib can help to control Ph+ ALL.
NCT06236724ClinicalTrials.gov ↗
To learn if asciminib can help to control CML. The safety and effects of this drug will also be studied.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.